Efficacy of rabeprazole (Razo®) in the treatment of various clinical variants of GERD: results from the GERBERA study

Introduction. Gastroesophageal reflux disease (GERD) is extremely common in the structure of gastroenterological diseases. Aim. To conduct a prospective observational post-marketing study of rabeprazole (Razo®) 20 mg taking once daily in patients with non-erosive reflux disease (NERD) after 2 and 4...

Descrizione completa

Dettagli Bibliografici

Autori principali:	V. V. Tsukanov, M. A. Cherepnin, A. V. Vasyutin, J. L. Tonkikh, E. V. Kasparov, N. A. Maslennikova, N. V. Pavlova
Natura:	Artigo
Lingua:	Russo
Pubblicazione:	Remedium Group LLC 2022-05-01
Serie:	Медицинский совет
Soggetti:	gerb esophagitis proton pump inhibitors rabeprazole treatment
Accesso online:	https://www.med-sovet.pro/jour/article/view/6857
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!